Skip to main content
Caplight Logo









Catalys Pacific

Catalys Pacific

Tokyo, Tokyocatalyspacific.com

Overview

An independent venture capital firm founded in 2019 that focuses on early-stage investments in life sciences, including biotherapeutics, MedTech, and diagnostics. The firm aims to bridge the innovation ecosystems of Japan and the United States, creating and investing in biotech companies.

Portfolio Companies

6

Investments

Catalys Pacific investments
CompanyDateStageLead
Crystalys TherapeuticsJul 2026Series BCo-investor
Crystalys TherapeuticsSep 2025Series ALead
Pathalys PharmaAug 2024Series BCo-investor
Renalys PharmaJul 2024Series ALead
Arialys TherapeuticsSep 2023SeedCo-investor
View all investments

Key People

Mitsuyuki MATSUMOTO

Operating Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersTokyo, Tokyo
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?